Wall Street Analysts See Johnson & Johnson (JNJ) as a Buy: Should You Invest?
unknown
📅 Published: 2025-11-11 14:30
📰 Source: Yahoo
📝 Words: 39
📝 Article Content
The average brokerage recommendation (ABR) for Johnson & Johnson (JNJ) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
📄 Summary
The average brokerage recommendation (ABR) for Johnson & Johnson (JNJ) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Scraping Metadata:
Scraped At:
Unknown
Created At:
2025-11-13 11:07:42
Updated At:
2025-11-13 11:07:42
Scraping Job ID:
N/A
Stock Mentions:
JNJ - Johnson & Johnson
Relevance: N/A
SO - The Southern Company
Relevance: N/A